New approach makes cancer cells explode
3/21/2014
Researchers at Karolinska Institutet in Sweden have discovered that a substance called Vacquinol-1 makes cells from glioblastoma, the most aggressive type of brain tumour, literally explode. When mice were given the substance, which can be given in tablet form, tumour growth was reversed and survival was prolonged. The findings are published in the journal Cell.
Deaths from breast cancer fall in Europe, but unexplained differences between countries remain
3/21/2014
Improvements in treatment, as well as enhanced access to care, underlie the sustained decreases in breast cancer mortality seen in 30 European countries [1] from 1989 to 2010.
Regular physical activity reduces breast cancer risk irrespective of age
3/21/2014
Practising sport for more than an hour a day reduces the risk of contracting breast cancer, and this applies to women of any age and any weight, and also unaffected by geographical location, according to research presented to the 9th European Breast Cancer Conference (EBCC-9).
Low levels of oxgen, nitric oxide worsen sickle cell disease
3/21/2014
Low levels of both oxygen and the powerful blood vessel dilator nitric oxide appear to have an unfortunate synergy for patients with sickle cell disease, researchers report. Their studies indicate that the two conditions common in sickle cell disease, dramatically increase red blood cells' adhesion to the lining of blood vessels walls and the debilitating pain crises that can result.
New drug offers potential for chemo-free treatment for leukemia/lymphoma
3/21/2014
Patients with terminal forms of leukaemia and lymphoma who have run out of treatment options could soon benefit from a new drug, which not only puts an end to chemotherapy and has virtually no side effects but also improves a patient's life expectancy and quality of life.
Extended hormone therapy may help some women with ER+ breast cancer
3/21/2014
Genetic analyses of results from 1125 postmenopausal women being treated for oestrogen responsive breast cancer have shown that some of them are more likely than others to have a late recurrence of their cancer and might benefit from ten years of hormone therapy rather than five.
Preterm babies can suffer life-threatening infections due to gut bacteria
3/21/2014
Babies born prematurely are surviving in increasing numbers. But many withstand complications of early birth only to suffer late-onset sepsis - life-threatening bloodstream infections that strike after infants reach 72 hours of age.While early-onset sepsis often is caused by pathogens acquired from the amniotic sac or birth canal, the causes of late-onset sepsis have been far less clear.
Ipilimumab in advanced melanoma: added benefit for non-pretreated patients not proven
3/21/2014
The German Institute for Quality and Efficiency in Health Care (IQWiG) already assessed the added benefit of ipilimumab in advanced melanoma in 2012. A considerable added benefit was found for patients who had already received previous treatment.
Highly accurate noninvasive colorectal cancer screening tool
3/21/2014
An Indiana University and Regenstrief Institute study of nearly 10,000 average-risk, asymptomatic men and women from 90 sites across the United States reports that a multi-target stool DNA test - a new noninvasive colorectal cancer screening tool that has not yet been approved for sale by the Food and Drug Administration - detects 92.3 percent of colon cancers, compared to only 73.
Breast cancer: lack of resources in low-income countries 'alarming'
3/21/2014
A presentation to be held at the 9th European Breast Cancer Conference today will reveal the latest figures that provide insight into the global burden of breast cancer. And although there are some signs of positivity in reducing this burden, it is clear there is still a lot more work to be done.According to Prof.